Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

The Global Pharmaceutical Warehousing Market was valued at approximately USD 26.01 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.7% over the forecast period 2024 ...

BEIJING, CN / ACCESS Newswire / May 16, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

Advancing development strategy for lead program TPI 287 to commence Phase 2 study around year end 2025 for treatment of glioblastoma multiforme (GBM) HOUSTON, TX / ACCESS Newswire / May 16, 2025 / CNS ...

If pharmaceutical companies don’t oblige, they may be forced into price standards on par with lower prices paid by other countries. Find Out: Mark Cuban Says Trump’s Executive Order To Lower M ...

The initial public offerings (IPOs) of Integrity Infrabuild Developers and Accretion Pharmaceuticals were fully subscribed on May 14. The IPO of Integrity Infrabuild Developers will close on May ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.56. Operator: Good day and thank you for standing by. Welcome to the Acumen Pharmaceuticals ...

He said he expects the order will reduce the cost of pharmaceuticals by 30% to 80%. "Our Country will finally be treated fairly, and our citizens [sic] Healthcare Costs will be reduced by numbers ...

At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation ...

HONOLULU (HawaiiNewsNow) - The state of Hawaii has entered into a $700 million settlement agreement with pharmaceutical giants Bristol-Myers Squibb (BMS) Company and three U.S.-based subsidiaries ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move comes as the S&P 500 and Nasdaq Composite both slipped slightly.